Robert J. Hugin - Dec 20, 2021 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Dec 20, 2021
Transactions value $
$0
Form type
4
Date filed
12/22/2021, 08:52 PM
Previous filing
May 24, 2021
Next filing
Apr 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Award $0 +3.42K $0.00 3.42K Dec 20, 2021 Common Shares 3.42K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2 The reporting person was granted 3,417 restricted share units on December 20, 2021, which vested immediately upon grant. These restricted share units will settle on a deferred basis upon the reporting person's retirement from the Board of Directors of the issuer.
F3 Not applicable.

Remarks:

Exhibit List: Exhibit 24: Power of attorney